Table 3 Lung [18F] FDG uptake analysis by survival and disease progression
From: [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
| Â | Survivor | Non-survivor | P value | Disease progression | No disease progression | P value |
|---|---|---|---|---|---|---|
SUV max | 3.9 ± 0.2 | 3.4 ± 0.2 | 0.2 | 3.7 ± 0.2 | 3.3 ± 0.4 | 0.1 |
SUV mean | 1.1 ± 0.1 | 0.9 ± 0.1 | 0.4 | 1.0 ± 0.1 | 0.8 ± 0.1 | 0.3 |
TLG (cm3) | 873.7 ± 184.9 | 1783 ± 230.6 | 0.005 | 1711 ± 149.5 | 945.3 ± 189.8 | 0.02 |
MLV (cm3) | 784.6 ± 175.6 | 1331.2 ± 154.0 | 0.029 | 657.7 ± 115.5 | 1307 ± 159.2 | 0.003 |